-transparent.png){kind=logo}
Inhibition of tissue-type plasminogen activator (t-PA) by pooled plasma could be ascribed for only 60% to the endothelial cell type PA inhibitor. The residual inhibition is ascribed to a so-far undescribed plasma component present at 0.2 nmol/l. This component shows reversible binding to t-PA with an apparent Ki of 10 pmol/l (does not hinder t-PA binding to fibrin); also reacts with urokinase, but not with DIP-t-PA; is stable at 37 degrees C and does not occur in media of endothelial cells, hepatocytes and fibroblasts. This PA binding component in plasma adds to the regulation of plasminogen activator activities.
Related Publications
C Kluft, and
A F Jie, and
E D Sprengers, and
J H Verheijen
December 1992,
Biochimica et biophysica acta,
C Kluft, and
A F Jie, and
E D Sprengers, and
J H Verheijen
October 1984,
Blood,
C Kluft, and
A F Jie, and
E D Sprengers, and
J H Verheijen
February 1978,
The Journal of physiology,
C Kluft, and
A F Jie, and
E D Sprengers, and
J H Verheijen
February 1996,
Scandinavian journal of gastroenterology,
C Kluft, and
A F Jie, and
E D Sprengers, and
J H Verheijen
January 1994,
Urologia internationalis,
C Kluft, and
A F Jie, and
E D Sprengers, and
J H Verheijen
October 1992,
Sheng li xue bao : [Acta physiologica Sinica],
C Kluft, and
A F Jie, and
E D Sprengers, and
J H Verheijen
June 1988,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
C Kluft, and
A F Jie, and
E D Sprengers, and
J H Verheijen
January 1997,
Cancer,
C Kluft, and
A F Jie, and
E D Sprengers, and
J H Verheijen
February 1996,
The journal of obstetrics and gynaecology research,
C Kluft, and
A F Jie, and
E D Sprengers, and
J H Verheijen
February 1987,
Cell structure and function,
